Schering Helps Merck Where It’s Needed Most: The Pipeline
Bulking up the pipeline is a frequent motive for a pharmaceutical merger - but somewhat unusual for Merck, a company that has long prided itself on the strength of its R&D activity
Bulking up the pipeline is a frequent motive for a pharmaceutical merger - but somewhat unusual for Merck, a company that has long prided itself on the strength of its R&D activity